The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.
Br J Cancer
; 103(3): 332-9, 2010 Jul 27.
Article
en En
| MEDLINE
| ID: mdl-20628389
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Taxoides
/
Anticuerpos Monoclonales
/
Neoplasias
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Br J Cancer
Año:
2010
Tipo del documento:
Article
País de afiliación:
Reino Unido